drugset / Trial / NCT02191241
Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®)
NaSingle-groupOpen-label
Summary
To describe the plasma and urinary pharmacokinetics of quercetin glucuronide and kaempferol glucuronide after the administration of a single peroral dose of 1,800mg Red Vine Leaf Extract (Antistax®). Additionally, the trial evaluated the safety and tolerability of this dose in healthy subjects.
Timeline
- Start
- 2001-08
- Primary completion
- 2004-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Red Vine Leaf Extract | Unknown | 1800 mg | Oral |
Indications
No indication recorded.